These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 36823755)

  • 1. Risk factors and prognosis for latent tuberculosis infection in dialysis patients: A retrospective cohort study at a single tertiary care center.
    Xia Y; Fan Q; Zhang J; Jiang L; Huang X; Xiong Z; Xiong Z
    Semin Dial; 2024; 37(1):59-64. PubMed ID: 36823755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of Tuberculosis Among Patients on Dialysis: The Predictive Value of Serial Interferon-Gamma Release Assay.
    Shu CC; Hsu CL; Wei YF; Lee CY; Liou HH; Wu VC; Yang FJ; Lin HH; Wang JY; Chen JS; Yu CJ; Lee LN
    Medicine (Baltimore); 2016 May; 95(22):e3813. PubMed ID: 27258523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the Prevalence of Latent Tuberculosis Infection among Non-Dialysis Patients with Severe Chronic Kidney Disease, Patients Receiving Dialysis, and the Dialysis-Unit Staff: A Cross-Sectional Study.
    Shu CC; Hsu CL; Lee CY; Wang JY; Wu VC; Yang FJ; Wang JT; Yu CJ; Lee LN
    PLoS One; 2015; 10(4):e0124104. PubMed ID: 25919813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Latent Tuberculosis Therapy Outcomes in Dialysis Patients: A Retrospective Cohort.
    Chiang LY; Baumann B; Romanowski K; Kumar D; Campbell JR; Djurdjev O; Morshed M; Sekirov I; Cook VJ; Levin A; Johnston JC
    Am J Kidney Dis; 2021 May; 77(5):696-703. PubMed ID: 32818551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of Active Tuberculosis within One Year after Tumor Necrosis Factor Inhibitor Treatment according to Latent Tuberculosis Infection Status in Patients with Inflammatory Bowel Disease.
    Kang J; Jeong DH; Han M; Yang SK; Byeon JS; Ye BD; Park SH; Hwang SW; Shim TS; Jo KW
    J Korean Med Sci; 2018 Nov; 33(47):e292. PubMed ID: 30450023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The clinical application of quantiferon TB-2G: its usefulness and limitations].
    Sato S; Nagai H
    Kekkaku; 2011 Feb; 86(2):101-12. PubMed ID: 21404654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of isoniazid salvage therapy for latent tuberculosis infection in patients with immune-mediated inflammatory disorders - A retrospective cohort study in Taiwan.
    Huang SF; Chen MH; Wang FD; Tsai CY; Fung CP; Su WJ
    J Microbiol Immunol Infect; 2018 Dec; 51(6):784-793. PubMed ID: 28739436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors and prevalence of latent tuberculosis infection in patients receiving long-term hemodialysis and peritoneal dialysis.
    Shu CC; Wu VC; Yang FJ; Pan SC; Lai TS; Wang JY; Wang JT; Lee LN
    PLoS One; 2012; 7(8):e42592. PubMed ID: 22916137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Latent Tuberculosis Infection and Associated Factors in Patients with Systemic Lupus Erythematosus: a Multicenter, Cross-Sectional Study.
    Zhang L; Ma Y; Jiang N; Zou X; Zhang Y; Zhang F; Zeng X; Zhao Y; Liu S; Zuo X; Wu H; Wu L; Li H; Zhang Z; Chen S; Zhu P; Zhang M; Qi W; Liu Y; Liu H; Shi X; Liu X
    Microbiol Spectr; 2023 Jun; 11(3):e0084823. PubMed ID: 37158726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nutritional Adequacy and Latent Tuberculosis Infection in End-Stage Renal Disease Patients.
    Baek SD; Jeung S; Kang JY
    Nutrients; 2019 Sep; 11(10):. PubMed ID: 31561559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of latent tuberculosis infection and its risk factors in Japanese hemodialysis patients.
    Ogawa Y; Harada M; Hashimoto K; Kamijo Y
    Clin Exp Nephrol; 2021 Nov; 25(11):1255-1265. PubMed ID: 34129132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for latent and active tuberculosis infection in the elderly at admission to residential care homes: A cost-effectiveness analysis in an intermediate disease burden area.
    Li J; Yip BHK; Leung C; Chung W; Kwok KO; Chan EYY; Yeoh E; Chung P
    PLoS One; 2018; 13(1):e0189531. PubMed ID: 29293514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon-gamma release assays for diagnosis of latent TB infection in chronic kidney diseases and dialysis patients.
    Hayuk P; Boongird S; Pornsuriyasak P; Bruminhent J
    Front Cell Infect Microbiol; 2022; 12():1046373. PubMed ID: 36452296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of Latent Tuberculosis Infection among Patients Undergoing Regular Hemodialysis in Disenfranchised Communities: A Multicenter Study during COVID-19 Pandemic.
    Ismail MB; Zarriaa N; Osman M; Helfawi S; Kabbara N; Chatah AN; Kamaleddine A; Alameddine R; Dabboussi F; Hamze M
    Medicina (Kaunas); 2023 Mar; 59(4):. PubMed ID: 37109612
    [No Abstract]   [Full Text] [Related]  

  • 15. Potential role of M. tuberculosis specific IFN-γ and IL-2 ELISPOT assays in discriminating children with active or latent tuberculosis.
    Chiappini E; Della Bella C; Bonsignori F; Sollai S; Amedei A; Galli L; Niccolai E; Del Prete G; Singh M; D'Elios MM; de Martino M
    PLoS One; 2012; 7(9):e46041. PubMed ID: 23029377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Frequency Distribution and Risk Factors for Latent Tuberculosis in Contact Persons: Cologne 2012-2016].
    Dwenger LV; Funke N; Stephany P; Suarez I; Wiesmüller GA; Neuhann F
    Pneumologie; 2021 Aug; 75(8):567-576. PubMed ID: 33971674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for Latent Tuberculosis Infection in Migrants With CKD: A Cost-effectiveness Analysis.
    Campbell JR; Johnston JC; Ronald LA; Sadatsafavi M; Balshaw RF; Cook VJ; Levin A; Marra F
    Am J Kidney Dis; 2019 Jan; 73(1):39-50. PubMed ID: 30269868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of Lipoprotein Z-Specific IgA in Tuberculosis and Latent Tuberculosis Infection.
    Xiao JN; Xiong Y; Chen Y; Xiao YJ; Ji P; Li Y; Wang SJ; Zhao GP; Cheng QJ; Lu SH; Wang Y
    Front Cell Infect Microbiol; 2017; 7():495. PubMed ID: 29250493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accurate diagnosis of latent tuberculosis in children, people who are immunocompromised or at risk from immunosuppression and recent arrivals from countries with a high incidence of tuberculosis: systematic review and economic evaluation.
    Auguste P; Tsertsvadze A; Pink J; Court R; Seedat F; Gurung T; Freeman K; Taylor-Phillips S; Walker C; Madan J; Kandala NB; Clarke A; Sutcliffe P
    Health Technol Assess; 2016 May; 20(38):1-678. PubMed ID: 27220068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimated Impact of World Health Organization Latent Tuberculosis Screening Guidelines in a Region With a Low Tuberculosis Incidence: Retrospective Cohort Study.
    Ronald LA; Campbell JR; Rose C; Balshaw R; Romanowski K; Roth DZ; Marra F; Schwartzman K; Cook VJ; Johnston JC
    Clin Infect Dis; 2019 Nov; 69(12):2101-2108. PubMed ID: 30856258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.